Filing Details
- Accession Number:
- 0001225208-16-034087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-27 11:03:27
- Reporting Period:
- 2016-05-26
- Filing Date:
- 2016-05-27
- Accepted Time:
- 2016-05-27 11:03:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194004 | A Frank Damelio | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-26 | 100,000 | $24.43 | 472,994 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-26 | 2,400 | $34.47 | 470,594 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-26 | 4,663 | $34.48 | 465,931 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-26 | 20,999 | $34.50 | 444,932 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-26 | 71,938 | $34.49 | 372,994 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-26 | 100,000 | $0.00 | 100,000 | $24.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-09-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,705 | Indirect | By Rule 16b-3 Plan |
Footnotes
- These options are fully exercisable.
Billionaire Hedge Funds
